Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic biomarkers for cholangiocarcinoma (CCA): state of the art.

Expert review of gastroenterology & hepatology - 1 May 2021

Lang Sven A, Bednarsch Jan, Joechle Katharina, Amygdalos Iakovos, Czigany Zoltan, Heij Lara, Ulmer Tom F, Neumann Ulf P

Abstract excerpt

Introduction:Although advances in understanding the molecular basis of cholangiocarcinoma (CCA) have been made, surgery is the only curative therapy option and the overall prognosis of patients suffering from the disease remains poor. Therefore, estimation of prognosis based on known and novel biomarkers is essential for therapy guidance of CCA in both, curative and palliative settings.Areas covered:An extensive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Bile Duct Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Proteins

Share to Cholangiocarcinoma

Share to Extracellular Vesicles

Share to Neoplastic Cells, Circulating

Share to Nucleic Acids

Share to Sarcopenia

Source

Identifiers

PMID: 33970740
DOI: 10.1080/17474124.2021.1912591

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic biomarkers for cholangiocarcinoma (CCA): state of the art.PMID 33970740Read ↗

Biomarkers for the Management of Cholangiocarcinoma: Unveiling New Horizons for Precision TherapySemantic proximity Read ↗

Cholangiocarcinoma: novel therapeutic targets.Semantic proximity Read ↗

Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic ApproachSemantic proximity Read ↗

The diagnostic/prognostic potential and molecular functions of long non-coding RNAs in the exosomes derived from the bile of human cholangiocarcinomaSemantic proximity Read ↗

The Diagnostic and Prognostic Potentials of Non-Coding RNA in CholangiocarcinomaSemantic proximity Read ↗

Pathogenesis of CholangiocarcinomaSemantic proximity Read ↗

Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinomaSemantic proximity Read ↗

Identification of Cholangiocarcinoma (CCA) Subtype-Specific BiomarkersSemantic proximity Read ↗

A transcriptome based molecular classification scheme for cholangiocarcinoma and subtype-derived prognostic biomarkerSemantic proximity Read ↗

Recent Advances in Understanding CholangiocarcinomaSemantic proximity Read ↗

Therapy for advanced cholangiocarcinoma: Current knowledge and future potential.Semantic proximity Read ↗

The Role of microRNAs in CholangiocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.